Inflammatix
Healthcare & Life Sciences
Recent Finacing
Series E
Recent Raise
$57M
Inflammatix develops molecular diagnostic tests, including the TriVerity™ Acute Infection and Sepsis Test, to improve the detection and treatment of sepsis in emergency departments.
Focus Areas
Molecular diagnostics
acute infection
sepsis test
regulatory filing
commercialization
emergency departments.
Investors
